Clinical trial
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage…
NCT00303628 · ECOG-ACRIN Cancer Research Group, Other · Terminated
Key facts
| NCT number | NCT00303628 |
|---|---|
| Title | Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer |
| Official title | Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients With Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation |
| Lead sponsor | ECOG-ACRIN Cancer Research Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin, fluorouracil, leucovorin calcium, bevacizumab |
| Enrollment | 355 |
| Start date | May 11, 2006 |
| Primary completion | Apr 1, 2015 |
| Completion | Feb 11, 2019 |
| First posted | Mar 17, 2006 |
| Last update posted | Jul 6, 2023 |
| Countries | Canada, Peru, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: